Fiduccia P - Search Results

1

Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center experience and a critical review of the literature.

Lombardi G, Zustovich F, Farina P, Fiduccia P, Della Puppa A, Polo V, Bertorelle R, Gardiman MP, Banzato A, Ciccarino P, Denaro L, Zagonel V. Lombardi G, et al. Among authors: fiduccia p. Anticancer Drugs. 2013 Jan;24(1):90-7. doi: 10.1097/CAD.0b013e32835aa5fd. Anticancer Drugs. 2013. PMID: 23075631 Review.

2

The combination of carmustine wafers and fotemustine in recurrent glioblastoma patients: a monoinstitutional experience.

Lombardi G, Della Puppa A, Zustovich F, Pambuku A, Farina P, Fiduccia P, Roma A, Zagonel V. Lombardi G, et al. Among authors: fiduccia p. Biomed Res Int. 2014;2014:678191. doi: 10.1155/2014/678191. Epub 2014 Apr 9. Biomed Res Int. 2014. PMID: 24812626 Free PMC article.

3

Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study.

Lombardi G, Bellu L, Pambuku A, Della Puppa A, Fiduccia P, Farina M, D'Avella D, Zagonel V. Lombardi G, et al. Among authors: fiduccia p. J Neurooncol. 2016 Jul;128(3):481-6. doi: 10.1007/s11060-016-2136-7. Epub 2016 May 11. J Neurooncol. 2016. PMID: 27165580

4

Bevacizumab as front-line treatment of brain metastases from solid tumors: a case series.

Zustovich F, Ferro A, Lombardi G, Zagonel V, Fiduccia P, Farina P. Zustovich F, et al. Among authors: fiduccia p. Anticancer Res. 2013 Sep;33(9):4061-5. Anticancer Res. 2013. PMID: 24023350

5

Role of dose exposure and inflammatory status in a single center, real-world analysis of sunitinib in patients with metastatic renal cell carcinoma.

Maruzzo M, Basso U, Diminutto A, Roma A, Zustovich F, Brunello A, Fiduccia P, Banzato A, Zattoni F, Zagonel V. Maruzzo M, et al. Among authors: fiduccia p. Future Oncol. 2016 Apr;12(7):909-19. doi: 10.2217/fon.16.14. Epub 2016 Feb 17. Future Oncol. 2016. PMID: 26883094

6

Newly Diagnosed Multifocal GBM: A Monocentric Experience and Literature Review.

Baro V, Cerretti G, Todoverto M, Della Puppa A, Chioffi F, Volpin F, Causin F, Busato F, Fiduccia P, Landi A, d'Avella D, Zagonel V, Denaro L, Lombardi G. Baro V, et al. Among authors: fiduccia p. Curr Oncol. 2022 May 11;29(5):3472-3488. doi: 10.3390/curroncol29050280. Curr Oncol. 2022. PMID: 35621670 Free PMC article. Review.

7

Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.

Lombardi G, Nicoletto MO, Gusella M, Fiduccia P, Dalla Palma M, Zuin A, Fiore D, Donach M, Zagonel V. Lombardi G, et al. Among authors: fiduccia p. Cancer Chemother Pharmacol. 2012 Mar;69(3):781-7. doi: 10.1007/s00280-011-1765-y. Epub 2011 Oct 29. Cancer Chemother Pharmacol. 2012. PMID: 22037881 Clinical Trial.

8

Bi-weekly liposomal doxorubicin for advanced breast cancer in elderly women (≥ 70 years).

Basso U, Roma A, Brunello A, Falci C, Fiduccia P, Banzato A, Bononi A, Gusella M, Vamvakas L, Zagonel V, Monfardini S. Basso U, et al. Among authors: fiduccia p. J Geriatr Oncol. 2013 Oct;4(4):340-5. doi: 10.1016/j.jgo.2013.07.004. Epub 2013 Aug 15. J Geriatr Oncol. 2013. PMID: 24472477

9

Diagnostic value of plasma and urinary 2-hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma.

Lombardi G, Corona G, Bellu L, Della Puppa A, Pambuku A, Fiduccia P, Bertorelle R, Gardiman MP, D'Avella D, Toffoli G, Zagonel V. Lombardi G, et al. Among authors: fiduccia p. Oncologist. 2015 May;20(5):562-7. doi: 10.1634/theoncologist.2014-0266. Epub 2015 Apr 10. Oncologist. 2015. PMID: 25862748 Free PMC article.

10

Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma.

Indraccolo S, Lombardi G, Fassan M, Pasqualini L, Giunco S, Marcato R, Gasparini A, Candiotto C, Nalio S, Fiduccia P, Fanelli GN, Pambuku A, Della Puppa A, D'Avella D, Bonaldi L, Gardiman MP, Bertorelle R, De Rossi A, Zagonel V. Indraccolo S, et al. Among authors: fiduccia p. Clin Cancer Res. 2019 Mar 15;25(6):1828-1837. doi: 10.1158/1078-0432.CCR-18-1892. Epub 2018 Dec 4. Clin Cancer Res. 2019. PMID: 30514778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page